GENERATING AN EFFECTIVE T-CELL BASED INFLUENZA VACCINE
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA201634
Grant search
Key facts
Disease
UnspecifiedStart & end year
20222026Known Financial Commitments (USD)
$1,008,844.89Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
University of MelbourneResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Vaccine design and administration
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Influenza is a highly contagious, rapidly spreading respiratory pathogen that causes profound morbidity and mortality. Current influenza vaccines are suboptimal, they need to be updated and administered annually, and provide no protection in the event of a pandemic influenza outbreak. This research program will see the development of a novel universal 'one-shot’ influenza vaccine that provides long term protection against both seasonal and newly emerging pandemic influenza strains.